The ACRF Single Cell Cancer Proteomics Laboratory has opened at the University of Sydney, providing scientists with advanced tools to examine individual cancer and immune cells in detail. The facility aims to investigate why some cancer cells survive treatment, regrow and spread.
According to the University of Sydney, the laboratory is supported by the Australian Cancer Research Foundation (ACRF) and is located within the university's research precinct. It will enable researchers to analyse proteins at the single-cell level, a capability that could reveal new insights into cancer resistance and metastasis.
The lab's focus on single-cell proteomics represents a growing area of cancer research, as traditional bulk analysis can mask differences between individual cells. By studying cancer and immune cells one by one, scientists hope to identify vulnerabilities that could lead to more effective treatments.
No specific operational dates or funding amounts were verifiable at the time of publication. The opening marks a significant addition to Australia's cancer research infrastructure.
